Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
Clinical trial NCT05240976 · RECRUITING
Trial details
- NCT number
- NCT05240976
- Sponsor
- China Medical University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2027-02-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.